-
Healthy Habits
Tanning TroubleIndoor tanning is a major culprit in melanoma diagnosed early in life.
by Kate Yandell
-
Screening Gets PersonalConflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
-
Making a MatchOncologists and researchers are looking for new drug combinations that extend patient survival without worsening side effects, but it's a daunting task.
by Stephen Ornes
-
Healthy Habits
Reaping Grains’ BenefitsStudies point to a reduced risk of cancer death from eating whole grains, but questions remain.
by Brenda Conaway
-
Healthy Habits
Put a Cork in ItDrinking alcohol increases the risk for at least seven types of cancer.
by Brenda Conaway
-
From the Editor-in-Chief
Cancer and the MicrobiomeAltering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.
by William G. Nelson, MD, PhD
-
Forward Look
What Is CRISPR?Q&A with oncologist Howard Kaufman on the new gene-editing tool.
by Chris Palmer
-
Forward Look
Longer Treatment May Benefit Some Breast Cancer PatientsTen years of hormone therapy studied.
by Sue Rochman
-
Forward Look
Addressing Depression in Adult Cancer SurvivorsStudy links depression to money woes and missed opportunities for follow-up.
by Marilyn Fenichel
-
Forward Look
Report Links Excess Weight to Eight More Cancer TypesReview increases number from five to 13.
by Kendall K. Morgan
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
